Gold Runner Exploration Inc. (CSE: GRUN) (FSE: CE70) (‘Gold Runner’ or the ‘Company’) is pleased to announce its intention to complete a non-brokered private...
TORONTO, ON / ACCESS Newswire / March 10, 2026 / 55 North Mining Inc. (CSE:FFF,OTC:FFFNF)(FSE:6YF) (‘55 North‘ or the ‘Company‘) is pleased to announce...
Highlights: Dolphin Area continued infill drilling demonstrates potential for higher grade within the main resource area and at depth with notable intercepts including: 2.41...
Summit Royalties Ltd. (TSXV: SUM,OTC:SUMMF, OTCQB: SUMMF) (the ‘Corporation’ or ‘Summit’) announces that it has granted an aggregate of 350,000 restricted share units of...
Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) (‘Homerun’ or the ‘Company’) is pleased to announce that researchers at the University of California, Davis (‘UC Davis’), in...
Not for distribution to United States newswire services or for dissemination in the United States. Grande Portage Resources Ltd. (TSXV:GPG)(OTCQB:GPTRF)(FSE:GPB) (‘Grande Portage’ or the...
(TheNewswire) As the proposed acquisition is subject to TSXV approval and the transaction is considered by the TSXV to be a ‘Fundamental Acquisition’, Section...
(TheNewswire) Consistent progress towards near term renewal of surface rights access in Peru December 10, 2024 TheNewswire – Vancouver, Canada – Element79 Gold Corp....
Mawson Finland Limited (‘Mawson’ or the ‘Company’) (TSX-V:MFL) is pleased to announcethe completion of the ‘first phase’ (‘EIA Program’) of the Environmental Impact Assessment...
The Trump administration’s ability to reign in government spending, quash inflation and bolster the economy were the most prevalent topics during the popular economy...
Lundin Mining (TSX:LUN,OTC Pink:LUNMF) has entered a definitive agreement to sell its Neves-Corvo operation in Portugal and Zinkgruvan operation in Sweden to Boliden (STO:BOL)...
Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402 Download the PDF here. This post appeared first on investingnews.com
Cleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles Health Download the PDF here. This post appeared first on investingnews.com